Abiopharma

WESBANCO INC (WSBC) Reports the reporting period Financial Results WESBANCO INC (WSBC) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $1
• Net Income: $2
• EPS: $19
• Cash and equivalents: $250 million
  • Targeting top-quartile average deposits per financial center versus peers, over long term Reinvest: Reinvesting resources in markets and locations with strong demand, including Tennessee and Florida Increasing average deposits per branch by 50+% since 12/31/2021